Firma ImmunOs Therapeutics, Autor bei Presse-Blog

ImmunOs Therapeutics Appoints Dr. Hilmar Ebersbach as Vice President Antibody Development and Protein Engineering

17. Oktober 2022 Firma ImmunOs TherapeuticsForschung und Entwicklungantibody, cancer, clinical, discovery, hla, immunos, immunotherapies, lab, new, protein, research, scil, therapy, treatment, with

ImmunOs Therapeutics AG, a biopharmaceutical company leveraging its HLA-based technology platform to develop first-in-class therapeutics for the treatment of cancer and autoimmune diseases, today announced the appointment of Dr. Hilmar Ebersbach as Vice President Antibody Development and Protein Engineering (ADPE). Mehr

ImmunOs Therapeutics Announces Appointment of Joseph Leveque, MD, to its Board of Directors

4. Oktober 20224. Oktober 2022 Firma ImmunOs TherapeuticsForschung und Entwicklungcancer, cedars, clinical, discovery, hla, immunos, kras, leveque, los, mba, merck, onyx, serono, therapy, with

ImmunOs Therapeutics AG, a biopharmaceutical company leveraging its HLA-based technology platform to develop first-in-class therapeutics for the treatment of cancer and autoimmune diseases, today announced that Joseph Leveque, MD, has been appointed to the Company´s Board of Directors. Dr. Leveque Mehr

ImmunOs Therapeutics schließt Serie B Finanzierung in Höhe von US $74 Millionen ab

7. Juni 2022 Firma ImmunOs TherapeuticsForschung und Entwicklungbiomed, capital, financial, fiscus, gimv, hla, immunos, lightspeed, milla, novartis, patienten, samsara, serie, Studie, therapeutics

. – Samsara, Lightspeed, Gimv und Mission BioCapital stärken als neue Anteilseigner das Investorenkonsortium und erweitern die transatlantische Präsenz – Unternehmen gründet US-Niederlassung zum Ausbau der internationalen Geschäftstätigkeit ImmunOs Therapeutics AG, ein biopharmazeutisches Unternehmen, das mit seiner HLA-basierten Technologieplattform neuartige Mehr

ImmunOs Therapeutics Announces Poster Presentation at the Society for Immunotherapy of Cancer 36th Annual Meeting (SITC)

13. Oktober 202113. Oktober 2021 Firma ImmunOs TherapeuticsGesundheit & Medizinamp, bio, cancer, company, convention, immune, immunos, immunotherapies, immunotherapy, innate, new, swiss, therapeutics, treatment, with

ImmunOs Therapeutics AG, a Swiss biotechnology company developing a new class of biologics for the treatment of cancer and autoimmune diseases, today announced that the Company will present a scientific poster at the upcoming Society for Immunotherapy of Cancer 36th Mehr

ImmunOs Therapeutics AG Receives Public Funding from Eurostars and Innosuisse for a Novel Therapeutic Antibody to Treat Inflammatory Rheumatic Diseases

12. April 202111. Mai 2021 Firma ImmunOs TherapeuticsGesundheit & Medizinbio, cancer, discovery, eurostars, hla, immunotherapies, mab, patients, psoriasis, sas, strong, swiss, tcr, umc, with

– ImmunOs Therapeutics AG, a Swiss bio-technology company developing a new class of biologics for the treatment of cancer and autoimmune diseases, announced today that is has received public funding from the European Union’s Eurostars-2 Programme and the Swiss Innovation Mehr

Autor: Firma ImmunOs Therapeutics